Back to search results

AI-driven Support to Reduce Hospital Blood Clots

This study is testing a new artificial intelligence (AI) tool called VTE-AI to help prevent hospital-acquired blood clots (HA-VTE), which are a serious health concern. The VTE-AI tool will provide alerts to doctors when a patient is at high risk for blood clots and is not receiving preventive medication. The goal is to see if using this AI tool can reduce the number of HA-VTE cases in hospitals within the Vanderbilt Health System. Anyone admitted to Vanderbilt Adult Hospital, Vanderbilt Tullahoma Harton Hospital, Vanderbilt Bedford County Hospital, or Vanderbilt Wilson County Hospital can potentially join. The study will measure how many new blood clots occur from when a patient is admitted until they leave the hospital. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 2236 participants. It will compare standard care to care that includes an AI-driven clinical decision support system.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from baseline until discharge from the hospital, which is approximately 2 to 5 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06939803

AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.

Recruiting
NAAll AgesInterventionalPrevention
Vanderbilt University Medical Center
~2,236 participants
Updated 2026-02-13 on ClinicalTrials.gov
What's tested:Risk model-driven CDS

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of Hospital Acquired VTE
Measured over Baseline to discharge from hospital, approximately 2 to 5 days

Conditions

Venothromboembolism

Explore related trials

Venous Thromboembolism

Where it's being run

1 sites across 1 states
Tennessee1

Who to contact

Colin Walsh
[email protected]
6153225000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Inpatient admission to Vanderbilt Adult Hospital, Vanderbilt Tullahoma Harton Hospital, Vanderbilt Bedford County Hospital, or Vanderbilt Wilson County Hospital

Exclusion

None

What this trial measures

  • Incidence of Hospital Acquired VTEBaseline to discharge from hospital, approximately 2 to 5 days

    Percentage of admissions in which patients were diagnosed with VTE more than 48 hours after admission, defined as "Hospital Acquired" in prior literature